Notes
2012 British pounds
Reference
Nazir J, et al. Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom. Value in Health 18: 783-90, No. 6, Sep 2015
Rights and permissions
About this article
Cite this article
Mirabegron cost effective for OAB in the UK. PharmacoEcon Outcomes News 738, 21 (2015). https://doi.org/10.1007/s40274-015-2503-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2503-1